Apixaban in patients with atrial fibrillation.

By S. Connolly, J. Eikelboom, C. Joyner, H. Diener, R. Hart, S. Golitsyn, G. Flaker, Á. Avezum, S. Hohnloser, R. Diaz and 22 more. New England Journal of Medicine, 2011

2,210 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/08d39aa6fbbfe26b21e678bfdaab52e97645cd79

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. M. Ezekowitz
2. J. Halperin
3. Robert M. Califf
4. Stanley Nattel
5. Alejandro Rabinstein
6. Joseph S. Alpert
7. Gerhard Hindricks
8. R. Redberg

In Neurology

1. Richard C. Becker
2. Alejandro Rabinstein

In Nutrition and Dietetics

1. J. Halperin

Citations in the corpus

• Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage (2016, background): “apixaban, and edoxaban), and secondary prevention of deep venous thrombosis or pulmonary embolism (rivaroxaban and apixaban only) [119–128].”